CB-103
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CB-103, covering 2024-01-16 to 2025-11-26. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL [Phase 2]